ArticleCellular and molecular life sciences : CMLS2026
Extracellular vesicles mediate intercellular transfer of PD-L1 and bystander T-cell suppression.
Article in Cellular and molecular life sciences : CMLS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Follicular Immune Checkpoint: PD-1/PD-L1 and Immune Tolerance in Oocyte Competence and IVF Failure.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Extracellular vesicles (EVs) carrying programmed death-ligand 1(PD-L1) on their membranes regulate immune responses. While membrane PD-L1 can be exchanged between tumor and immune cells through immune synapse, it remains unclear whether PD-L1 exchange occurs in non-immune cells. Here, we investigated the transfer of PD-L1 onto the surface of various recipient cells via EVs. Genetically engineered 293T PD-L1+ cells, when co-cultured with PD-L1neg isogenic or heterologous cells, showed a ~ 6 to 22-fold increase in surface PD-L1 on 100% of PD-L1neg bystander recipient cells. Purified PD-L1+ EVs retained competency to transfer PD-L1 to recipient PD-L1neg cell surfaces (> six fold increase). Importantly, transferred PD-L1 mediates binding to PD-1 and facilitates suppression of proliferation of activated T cells. Metabolically inert PD-L1neg 293T cells also acquired PD-L1 on their surfaces from PD-L1+ cells, or PD-L1+EVs, indicating a passive transfer mechanism independent of active cellular uptake. Overall, these findings reveal a distinct, passive and functional mechanism of PD-L1 transfer via EVs, defining previously underappreciated cell-physiological pathway that enables immune suppression and evasion by PD-L1neg somatic cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.